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ABSTRACT 
The purpose of this study is to investigate antioxidant and anticancer 
activities of Scurrula ferruginea extracts. The antioxidant activities of the extracts 
were evaluated using various assays. The extracts were further investigated to 
examine their cytotoxic activity on human breast cancer cell lines; MDA-MB-231, 
MDA-MB-468 and MCF-7 using MTT assay. Microscopic examinations of cells 
were carried out to elucidate the modes of cell death. The effect of the extracts on 
cancer cells colony formation and migration were determined. Changes in 
mitochondrial membrane potential and level of reactive oxygen species (ROS) were 
measured. Western blot and cell cycle analysis were performed to unravel the 
mechanism of action of extracts against the breast cancer cells. Using GC-MS 
analysis, chemical composition of extracts were characterized to reveal the presence 
of anti-cancerous compounds. Our study on stem methanol extract has shown the 
highest amount of phenolic, flavonoid contents, strong DPPH radical scavenging and 
metal chelation activity in comparison to other extracts. The stem aqueous and 
methanol extracts have shown higher cytotoxic effect towards MDA-MB-231 cells 
compared to other cell lines with IC50 value of 50.35 and 19.27 µg/mL, after 72 h of 
treatment, respectively. Morphological observations revealed properties of apoptosis 
in the treated cells. The results displayed that the extracts have the ability to stop 
migration of cancer cells and also inhibit the colony formation of cancer cells. 
Moreover, the results have shown that the extracts induced apoptosis in breast cancer 
cells by ROS generation and mitochondrial depolarization. Furthermore, this study 
demonstrated that methanol extract inhibited the proliferation of breast cancer cells 
via induction of cell cycle arrest at G0/G1 phase and apoptosis through a 
mitochondria-dependent apoptosis pathway. The findings of present study revealed 
the potential antioxidant and anticancer activities of S. ferruginea stem methanol 
extract which may serve as a promising candidate in the search of a new anti-cancer 
drug.  
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ABSTRAK 
Tujuan kajian penyelidikan ini adalah untuk mengkaji aktiviti antioksida dan 
antikanser bagi ekstrak Scurrula ferruginea. Aktiviti antioksida bagi ekstrak 
dianalisa menggunakan pelbagai kaedah asai. Ekstrak tersebut juga dikaji secara 
lebih mendalam untuk mengenal pasti aktiviti sitotoksik terhadap garisan sel kanser 
payudara; MDA-MB-231, MDA-MB-468 dan MCF-7 menggunakan asai MTT. 
Analisis mikroskopik terhadap sel-sel telah dilaksanakan untuk menghuraikan mod 
kematian sel. Kesan daripada ekstrak terhadap pembentukan dan migrasi koloni 
kanser telah ditentukan. Perubahan kepada keupayaan membran mitokondria dan 
tahap reaktif spesies oksigen (ROS) telah diukur. Western blot dan analisis kitaran 
sel telah digunapakai untuk menguraikan mekanisme tindakan bagi ekstrak terhadap 
sel-sel kanser payudara. Dengan menggunakan analisis GC-MS, komposisi kimia 
bagi ekstrak telah dicirikan dan menunjukkan kehadiran sebatian anti-kanser. 
Ekstrak methanol batang memberikan kuantiti fenolik dan flavonoid yang sangat 
tinggi serta aktiviti penyingkiran radikal DPPH dan pengelatan logam yang kukuh 
berbanding ekstrak yang lain. Ekstrak akueus dan methanol dari batang 
menunjukkan kesan sitotoksik yang lebih tinggi terhadap sel MDA-MB-231 
berbanding garisan sel yang lain dengan nilai IC50 masing-masing sebanyak 50.35 
dan 19.27 µg/mL setelah 72 jam rawatan. Pemerhatian morfologi mendedahkan ciri-
ciri apoptosis dalam sel-sel yang dirawat. Hasil kajian menunjukkan bahawa ekstrak-
ekstrak tersebut mempunyai keupayaan untuk memberhentikan migrasi sel-sel 
kanser di samping menghalang pembentukan koloni sel-sel kanser. Tambahan pula, 
hasil kajian menunjukkan bahawa ekstrak-ekstrak mencetuskan apoptosis dalam sel-
sel kanser payu dara melalui penjanaan ROS dan penyahkutuban mitokondria. Selain 
itu, kajian ini juga menunjukkan bahawa ekstrak methanol menghalang penyebaran 
sel-sel kanser payu dara dengan merencatkan kitaran sel pada fasa G0/G1 dan 
apoptosis melalui satu laluan apoptosis yang mempunyai pergantungan terhadap 
mitokondria. Hasil kajian menunjukkan bahawa aktiviti antioksida dan antikanser 
bagi ekstrak methanol dari batang S. ferruginea berpotensi menjadi calon kepada 
pencarian ubat anti-kanser baru.  
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CHAPTER 1 
1 INTRODUCTION 
1.1 Research Background 
1.1.1 Breast Cancer 
Cancer of breast formed due to formation of malignant tumor in the cells of 
breast. Initially the growth of breast cancer is local which is followed by extension 
within lymph vessels into regional lymph nodes and invasion of small vein which 
results in systematic metastatic spread (Spratt & Tobin, 1995). Breast cancer is the 
most common type of non-skin malignancy among women worldwide. It has been 
reported that the incidence and mortality of breast cancer have increased during the 
last two decades (American Cancer Society Global Cancer Facts & Figures 2nd 
Edition, 2011; Jemal et al., 2011; Ferlay et al., 2013). Based on 2006-2010 statistics, 
the number of deaths in the United States was 22.6 per 100,000 women per year. It is 
predicted that an estimated 231,840 new cases of breast cancer and 40,730 breast 
cancer-related deaths will occur among women in 2015 worldwide (“American 
Cancer Society. Cancer Facts & Figures,” 2015)  
The incidence rate of breast cancer is highest in North America with the age 
standardized rates of 99.4 per 100,000 population, followed by countries in the 
Eastern Europe, South America, Southern Africa, and western Asia with moderate 
incidence rates, while the lowest incidence rates are reported in most African 
countries (Yip et al., 2006; Ferlay et al., 2010).  
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It is reported that approximately one million female are diagnosed with breast 
malignancy with an estimated 410,000 deaths every year, worldwide (Coughlin & 
Ekwueme, 2009). The incidence and mortality of breast cancer was reported lower in 
low-resource countries compared to high-resource countries (Smith, 2006). In most 
of the Asian countries, the incidence rate of breast cancer is increasing (Abdullah et 
al., 2013). An increasing in the prevalence of breast cancer was reported in Malaysia 
as well (Abdullah et al., 2013). The highest incidence rate for breast cancer in 
Malaysia was observed at women between 50-60 years old (Dahlui et al., 2011). It is 
estimated that one out of twenty Malaysian women have chance to get breast cancer 
at some point of their lives (Dahlui et al., 2011).  
Breast cancer is the most common cancer among Malaysian women (Lim et 
al., 2008). The National Cancer Registry (NCR) 2003-2005 reported an age-
standardized rate (ASR) of 47.3 per 100 000. The incidence is highest in Chinese 
(59.9 per 100 000) followed by Indians (54.2 per 100 000) and Malays (34.9 per 100 
000) (Lim et al., 2008). The International Agency for Research in Cancer 
(GLOBOCAN) 2012 estimated the ASR of breast cancer in Malaysia as 38.7 per 
100,000 with 5410 new cases in 2012 (“http://globocan.iarc.fr,”). 
1.1.2 Breast Cancer Treatment   
Different treatment options are currently available including local therapy and 
systemic therapy. Local therapy includes surgery, radiotherapy or a combination of 
the two, applied to kill cancer cells from a limited (local) area such as lymph nodes, 
breast and chest wall. Systemic therapy includes endocrine or hormone therapy and 
chemotherapy which administered following primary surgery or radiotherapy to kill 
or inhibit metastases and to improve survival. Table 1.1 represents various methods 
of breast cancer treatment and their common side effects. Selection of treatment 
strategies depend on tumor size, metastatic potential, axillary lymph node status and 
molecular and patient profile (Liao et al., 2013). Systemic therapy with cytotoxic 
chemotherapy and endocrine therapy were found to be effective in prolonging 
disease-free and survival time (Peto et al., 2000). 
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Table 1.1: Summary of various methods of breast cancer treatment and their 
common side effects. 
Methods 
Mechanism of 
action 
Side effects References 
Surgery 
Conservative and 
mastectomy 
Lymphedema, 
chronic nerve 
damage, infection at 
the incision site, 
armpit discomfort 
 
 (Karen  et al., 2002;   
Ridner et al., 2011) 
Radiotherapy 
Using high dose of 
radiation 
Skin reactions of the 
area being radiated 
 (Sjövall et al., 
2010) 
Biological targeted 
therapy 
Using monoclonal 
antibody and 
medicine 
  
 
Herceptin 
(Trastuzumab) 
 
Weakness, diarrhea, 
Pain, fever 
 
 (Nahta et al., 2006) 
 
Tykerb (lapatinib) 
 
Itchy and dry skin, 
diarrhea 
 
Endocrine or 
hormone therapy  
 
Using aromatase 
inhibitors and 
tamoxifen by 
blocking the action 
of estrogen 
 
 
 (Kalidas & Brown, 
2005;    
Connor & Attai, 
2013) 
 Tamoxifen: 
Vaginal discharge, 
an increase in 
thromboembolic 
events and uterine 
sarcoma 
 
 
 
Aromatase 
inhibitors: 
 
Musculoskeletal 
adverse effect ,hot 
flashes, increased 
LDL, loss of libido, 
vaginal dryness 
 
 
Chemotherapy 
The most commonly 
type of treatment 
using anti-breast 
cancer drugs 
 
 
(Yao et al., 2007;  
Chandwani et al., 
2012;   
Gianni et al., 2008) 
 
Carboplatin, 
Cisplatin: 
Cyclophosphamide: 
Nephrotoxicity  
Pulmonary toxicity 
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Despite of varied side effects, using chemotherapy either as a single 
compound or combination therapy with multiple-agents is still the most commonly 
used treatment option by breast cancer patients (Ozer et al., 2000). Chemotherapy 
uses anti-breast cancer drugs and cytotoxic agents for treatment of metastatic breast 
cancer (ER-negative tumors). Tumor cell response to chemotherapy and cytotoxic 
agents through an active form of cell death is known as apoptosis or programmed 
cell death. It is now well stablished that other modes of cell death such as necrosis 
and autophagy also take place following chemotherapy in tumor cells (Brown & 
Attardi, 2005).  
1.2 Problem Statement  
Although many treatment methods are currently established including 
surgery, radiotherapy, biological therapy, hormone therapy and chemotherapy, these 
therapies are less effective and recurrence is still occurring in breast cancer patients 
due to side effects and toxicity of drugs in normal cell and aggressive behaviour of 
the tumours (Table 1.3). In spite of many improvement in the use of hormonal and 
adjuvant cytotoxic therapies in breast cancer patients, there is no considerable 
reduction in mortality of breast cancer today (Eggenschwiler et al., 2007). Costly 
treatment methods and serious side effects associated with available therapies may 
cause greater tendencies among people to use herbal medicines for health care. 
Complementary and alternative medicine (CAM) as one of the major aspect 
of cancer therapy has been developed in last few years in order to alleviate drug side 
effects and relief pain in breast cancer patients (Ostermann et al., 2009). A large 
proportion of cancer patients (up to 80%) use complementary and alternative 
medicine (CAM) (Vardy et al., 2013). Breast cancer patients are among the most 
likely users of CAM (Bennett et al., 2009). Among CAM, herbal supplements (anti-
oxidants) is the most commonly used group of cancer treatment. Cancer treatment 
using herbal medicine has a history of more than 2000 years (Craig, 1999). 
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Harmful effects of conventional treatment as well as toxicity of 
chemotherapy create a significant problem in breast cancer therapy. The alternate 
solution to decrease side effects of chemotherapeutic drugs is the use of medicinal 
plants. Use of medicinal plants which have fewer side effects as compared to 
synthetic drugs can provides an alternative to the use of conventional allopathic 
medicine for treatment of breast cancer. In addition, any practical solution to manage 
cancer progression is of paramount importance. Therefore, there is a need to evaluate 
whether medicinal plant extracts are able to act as potent anticancer agent by 
controlling the cancer progression or arresting the carcinogenic process.  
Previous research findings have shown that various European mistletoe 
extracts from different host trees are capable of inducing apoptosis and cell death in 
numerous tumor cells and human cancer cell lines (Ramaekers et al., 2007;   
Harmsma et al., 2006). 
Although various studies investigated the effect of European mistletoe on 
cancer, not many studies focused on other species of mistletoe from other continents. 
Malaysia’s rainforest being part of the world’s tropical rainforest is also considered 
as one of the most evolved and diverse rainforest in the world. Scurrula. ferruginea 
is one of the mistletoe species in Malaysia which is used as a folk medicine for 
treatment of several ailments (Barlow, 1991). It has been reported that a decoction of 
S. ferruginea leaves along with Millettia sericea used for bathing malarial patients. 
In addition, a poultice of the pounded leaves administered as a post-partum 
protective medicine and also applied for snake bite and wound (Burkill et al., 1966) 
(Perry, 1978). Moreover, this plant are traditionally employed in the treatment of 
many diseases including gastrointestinal malfunction, high blood pressure and 
hypertension (Ameer et al., 2009).  
Ethno-medical knowledge plays an important role in selection of plants for 
discovery of novel drugs. Therefore, S. ferruginea was selected for the present study 
based on its reputation in folk medicine. There is no report on antioxidant capacity, 
anticancer activity and mechanism of action of S. ferruginea. The current study 
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provide the scientific rational for antioxidant and anti-breast cancer activities of S. 
ferruginea.   
1.3 Objectives of Study 
Based on the above-mentioned problem statements, the objectives of the 
present study are as follow:  
1. To evaluate potential of S. ferruginea crude extracts based on the 
antioxidant activity and phytochemical analysis 
2. To investigate the selective cytotoxic effects of selected extracts on 
breast cancer cells and study apoptosis-inducing effects of extracts  
3. To study the mechanism of growth arrest and unravel apoptotic 
pathway involve in breast cancer cell death by selected extract  
1.4 Scope of Study 
Aerial parts of S. ferruginea (Jack) Danser including stems, leaves and 
flowers were used in the present study. Different types of breast cancer cell lines 
including MCF-7 (luminal A breast carcinoma), MDA-MB-231(Claudin-low breast 
carcinoma) and MDA-MB-468 (basal-like breast carcinoma) which are differ in 
molecular markers status and invasiveness have been selected for the present study. 
To achieve the listed objectives, the study was confined to the following 
scopes: 
1. Determination of total phenolic and total flavonoid content by Folin-
Ciocalteu and aluminum chloride methods, respectively and 
antioxidant activities of different extracts by assessing DPPH free 
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radical scavenging activity, ABTS and metal chelation capacity of S. 
ferruginea extracts.  
2. Analysis of chemical composition using GC-MS of S. ferruginea 
extracts.  
3. Evaluation of selective cytotoxic activities of selected extracts against 
breast cancer cell lines and non-cancerous cell line using MTT assay 
and characterization of the cell death using AO/EB and Hoechst/PI 
staining methods.  
4. Determination of cell migration inhibition efficiency and colony 
forming ability of treated cancer cells using scratch assay and colony 
forming assay respectively.  
5. Measurement of mitochondrial membrane potential by JC-1 assay and 
investigation on the potential mechanism of apoptosis as the result of 
oxidative stress by measuring intracellular ROS level using DCF-DA 
assay.  
6. Determination of cell death mechanism pathway of selected extract 
against breast cancer cell through the regulation of bcl-2, bax, 
caspase-3, caspase-7 and PARP proteins using western blot analysis 
and possible cell cycle arrest using flow cytometric analysis.  
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1.5 Significant of Study 
i. Growth inhibitory effects on different carcinoma cell types may be 
crucial for effective control of breast cancer; therefore, the present 
study is of great importance to introduce a novel candidate in battling 
breast cancer particularly ER-negative breast carcinoma.  
ii. The present study is also paving the way for further research on S. 
ferruginea in the field of pharmaceutical industry and anti-cancer drug 
discovery for the development of anticancer agents.  
iii. This study provides an experimental basis for systematic and clinical 
research of medicines for treatment of breast cancer in the future. 
1.6 Methodology 
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